Multi-synergistic chemotherapeutic drug assemblies to activate colorectal cancer immunotherapy by modulating the multilevel immunosuppressive characteristics

Abstract

The life-threatening colorectal cancer exhibits multilevel immunosuppressive characteristics, including low immunogenicity, abnormal cellular metabolism, and acidic immunosuppressive microenvironment. In this work, multi-synergistic chemotherapeutic drug assemblies are fabricated to activate colorectal cancer immunotherapy by modulating the multilevel immunosuppressive characteristics. Without any drug excipients, the glycolysis inhibitor of lonidamine (LON), indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor of NLG919 (NLG), and the photosensitizer of chlorine e6 could self-assemble into drug assemblies (LNC) with uniform nano-size distribution and increased drug stability. Moreover, LNC could also promote cellular uptake and enhance drug penetration to enable efficient drug co-delivery. Especially, the photodynamic therapy (PDT) of LNC could disrupt tumor cells to release tumor-associated antigens, thus efficiently suppressing primary tumor growth and improving tumor immunogenicity. Meanwhile, LNC could also reduce the activity of IDO-1 and attenuate the glycolysis metabolism, thereby reversing the multilevel immunosuppressive characteristics to promote T cell activation. Benefiting from the multi-synergistic effects, LNC efficiently eradicates the primary tumor growth and also activates systemic antitumor immunity for metastatic tumor inhibition. Such a simple formulation but a multi-synergistic strategy may accelerate the development of translational nanomedicine for colorectal cancer immunotherapy by using small molecular drug combinations.

Keywords

colorectal cancer / drug assemblies / immunotherapy / photodynamic therapy / tumor metabolism

References

[1] X. Xiong, S. Chen, J. Shen, H. You, H. Yang, C. Yan, Z. Fang, J. Zhang, X. Cai, X. Dong, T. Kang, W. Li, P. Zhou, Signal Transduct. Target. Ther. 2022, 7, 99.

[2] Z. Wang, N. Little, J. Chen, K. T. Lambesis, K. T. Le, W. Han, A. J. Scott, J. Lu, Nat. Nanotechnol. 2021, 16, 1130.

[3] S. Eschweiler, J. Clarke, C. Ramírez-Suástegui, B. Panwar, A. Madrigal, S. J. Chee, I. Karydis, E. Woo, A. Alzetani, S. Elsheikh, C. J. Hanley, G. J. Thomas, P. S. Friedmann, T. Sanchez-Elsner, F. Ay, C. H. Ottensmeier, P. Vijayanand, Nat. Immunol. 2021, 22, 1052.

[4] X. Liu, X. Bao, M. Hu, H. Chang, M. Jiao, J. Cheng, L. Xie, Q. Huang, F. Li, C. Y. Li, Nature 2020, 588, 693.

[5] D. Shi, X. Wu, Y. Jian, J. Wang, C. Huang, S. Mo, Y. Li, F. Li, C. Zhang, D. Zhang, H. Zhang, H. Huang, X. Chen, Y. A. Wang, C. Lin, G. Liu, L. Song, W. Liao, Nat. Commun. 2022, 13, 5644.

[6] A. R. Parikh, A. Szabolcs, J. N. Allen, J. W. Clark, J. Y. Wo, M. Raabe, H. Thel, D. Hoyos, A. Mehta, S. Arshad, D. J. Lieb, L. C. Drapek, L. S. Blaszkowsky, B. J. Giantonio, C. D. Weekes, A. X. Zhu, L. Goyal, R. D. Nipp, J. S. Dubois, E. E. Van Seventer, B. E. Foreman, L. E. Matlack, L. Ly, J. A. Meurer, N. Hacohen, D. P. Ryan, B. Y. Yeap, R. B. Corcoran, B. D. Greenbaum, D. T. Ting, T. S. Hong, Nat. Cancer 2021, 2, 1124.

[7] W. Lu, W. Yu, J. He, W. Liu, J. Yang, X. Lin, Y. Zhang, X. Wang, W. Jiang, J. Luo, Q. Zhang, H. Yang, S. Peng, Z. Yi, S. Ren, J. Chen, S. Siwko, R. Nussinov, F. Cheng, H. Zhang, M. Liu, EMBO Mol. Med. 2021, 13, e12798.

[8] E. X. Chen, D. J. Jonker, J. M. Loree, H. F. Kennecke, S. R. Berry, F. Couture, C. E. Ahmad, J. R. Goffin, P. Kavan, M. Harb, B. Colwell, S. Samimi, B. Samson, T. Abbas, N. Aucoin, F. Aubin, S. L. Koski, A. C. Wei, N.M. Magoski, D. Tu, C. J. O’Callaghan, JAMA Oncol. 2020, 6, 831.

[9] D. V. F auriello, S. Palomo-Ponce, D. Stork, A. Berenguer-Llergo, J. Badia-Ramentol, M. Iglesias, M. Sevillano, S. Ibiza, A. Cañellas, X. Hernando-Momblona, D. Byrom, J. A. Matarin, A. Calon, E. I. Rivas, A. R. Nebreda, A. Riera, C. S. Attolini, E. Batlle, Nature 2018, 554, 538.

[10] V. Rajamanickam, C. Ballesteros-Merino, K. Samson, D. Ross, B. Bernard, B. A. Fox, E. Tran, P. Newell, T. Duhen, Cancer Immunol. Res. 2021, 9, 602.

[11] T. Gutting, E. Burgermeister, N. Härtel, M. P. Ebert, Semin Cancer Biol. 2019, 55, 78.

[12] Y. Zheng, Y. Han, Q. Sun, Z. Li, Exploration 2022, 2, 20210166.

[13] G. L. Beatty, P. J. O’Dwyer, J. Clark, J. G. Shi, K. J. Bowman, P. A. Scherle, R. C. Newton, R. Schaub, J. Maleski, L. Leopold, T. F. Gajewski, Clin. Cancer Res. 2017, 23, 3269.

[14] Y. Ding, Y. Wang, Q. Hu, Exploration 2022, 2, 20210106.

[15] T. Cascone, J. A. McKenzie, R. M. Mbofung, S. Punt, Z. Wang, C. Xu, L. J. Williams, Z. Wang, C. A. Bristow, A. Carugo, M. D. Peoples, L. Li, T. Karpinets, L. Huang, S. Malu, C. Creasy, S. E. Leahey, J. Chen, Y. Chen, H. Pelicano, C. Bernatchez, Y. N. V. Gopal, T. P. Heffernan, J. Hu, J. Wang, R. N. Amaria, L. A. Garraway, P. Huang, P. Yang, I. I. Wistuba, S. E. Woodman, J. Roszik, R. E. Davis, M. A. Davies, J. V. Heymach, P. Hwu, W. Peng, Cell Metab. 2018, 27, 977.e4.

[16] P. Seth, E. Csizmadia, A. Hedblom, M. Vuerich, H. Xie, M. Li, M. S. Longhi, B. Wegiel, Cancer Res. 2017, 77, 3632.

[17] F. Kitamura, T. Semba, N. Yasuda-Yoshihara, K. Yamada, A. Nishimura, J. Yamasaki, O. Nagano, T. Yasuda, A. Yonemura, Y. Tong, H. Wang, T. Akiyama, K. Matsumura, N. Uemura, R. Itoyama, L. Bu, L. Fu, X. Hu, F. Wei, K. Mima, K. Imai, H. Hayashi, Y. I. Yamashita, Y. Miyamoto, H. Baba, T. Ishimoto, JCI Insight 2023, 8, e163022.

[18] Z. H. Wang, W. B. Peng, P. Zhang, X. P. Yang, Q. Zhou, EBioMedicine 2021, 73, 103627.

[19] E. N. Van Meter, J. A. Onyango, K. A. Teske, Eur. J. Med. Chem. 2020, 188, 112008.

[20] Z. Fan, Y. Tian, Z. Chen, L. Liu, Q. Zhou, J. He, J. Coleman, C. Dong, N. Li, J. Huang, C. Xu, Z. Zhang, S. Gao, P. Zhou, K. Ding, L. Chen, EMBO Mol. Med. 2020, 12, e11571.

[21] S. Miyamoto, K. Azuma, H. Ishii, A. Bessho, S. Hosokawa, N. Fukamatsu, H. Kunitoh, M. Ishii, H. Tanaka, H. Aono, Y. Nakahara, K. Kusaka, Y. Hosomi, N. Kikuchi, Y. Mori, H. Itani, A. Hamada, K. Yamada, H. Okamoto, JAMA Oncol. 2020, 6, e201250.

[22] Y. Zhang, Z. Wang, Y. Huang, M. Ying, Y. Wang, J. Xiong, Q. Liu, F. Cao, R. Joshi, Y. Liu, D. Xu, M. Zhang, K. Yuan, N. Zhou, J. Koropatnick, W. Min, Signal Transduct. Target. Ther. 2018, 3, 28.

[23] Y. Zheng, H. Qin, S. J. Frank, L. Deng, D. W. Litchfield, A. Tefferi, A. Pardanani, F. T. Lin, J. Li, B. Sha, E. N. Benveniste, Blood 2011, 118, 156.

[24] X. Zhang, J. Wan, F. Mo, D. Tang, H. Xiao, Z. Li, J. Jia, T. Liu, Adv. Sci. 2022, 9, e2201819.

[25] Y. Wang, D. Gao, Y. Liu, X. Guo, S. Chen, L. Zeng, J. Ma, X. Zhang, Z. Tian, Z. Yang, Bioact. Mater. 2020, 6, 1513.

[26] X. Li, J. F. Lovell, J. Yoon, X. Chen, Nat. Rev. Clin. Oncol. 2020, 17, 657.

[27] W. Bao, F. Tian, C. Lyu, B. Liu, B. Li, L. Zhang, X. Liu, F. Li, D. Li, X. Gao, S. Wang, W. Wei, X. Shi, Y. Li, Sci. Adv. 2021, 7, eaba2458.

[28] S. Y. Qin, A. Q. Zhang, S. X. Cheng, L. Rong, X. Z. Zhang, Biomaterials 2017, 112, 234.

[29] L. P. Zhao, R. R. Zheng, H. Q. Chen, L. S. Liu, X. Y. Zhao, H. H. Liu, X. Z. Qiu, X. Y. Yu, H. Cheng, S. Y. Li, Nano Lett. 2020, 20, 2062.

[30] L. P. Zhao, R. R. Zheng, J. Q. Huang, X. Y. Chen, F. A. Deng, Y. B. Liu, C. Y. Huang, X. Y. Yu, H. Cheng, S. Y. Li, ACS Nano 2020, 14, 17100.

[31] S. Fu, G. Li, W. Zang, X. Zhou, K. Shi, Y. Zhai, Acta Pharm. Sin. B 2022, 12, 92.

[32] S. Karaosmanoglu, M. Zhou, B. Shi, X. Zhang, G. R. Williams, X. Chen, J. Control. Release 2021, 329, 805.

[33] Y. W. Liu, S. T. Xu, Q. Y. Lyu, Y. Huang, W. P. Wang, Aggregate 2024, 5, e443.

[34] L. Zhao, R. Zheng, L. Liu, X. Chen, R. Guan, N. Yang, A. Chen, X. Yu, H. Cheng, S. Li, Biomaterials 2021, 275, 120970.

[35] W. Ngamcherdtrakul, J. Morry, S. Gu, D. J. Castro, S. M. Goodyear, T. Sangvanich, M. M. Reda, R. Lee, S. A. Mihelic, B. L. Beckman, Z. Hu, J. W. Gray, W. Yantasee, Adv. Funct. Mater. 2015, 25, 2646.

[36] T. M. Allen, P. R. Cullis, Science 2004, 303, 1818.

[37] R. Zhang, R. Xing, T. Jiao, K. Ma, C. Chen, G. Ma, X. Yan, ACS Appl. Mater. Interfaces 2016, 8, 13262.

[38] K. Liu, R. Xing, Q. Zou, G. Ma, H. Möhwald, X. Yan, Angew. Chem. Int. Ed. 2016, 55, 3036.

[39] B. Rathore, K. Sunwoo, P. Jangili, J. Kim, J. H. Kim, M. Huang, J. Xiong, A. Sharma, Z. Yang, J. Qu, J. S. Kim, Biomaterials 2019, 211, 25.

[40] D. Vercauteren, J. Rejman, T. F. Martens, J. Demeester, S. C. De Smedt, K. Braeckmans, J. Control. Release 2012, 161, 566.

[41] G. Pasparakis, T. Manouras, M. Vamvakaki, P. Argitis, Nat. Commun. 2014, 5, 3623.

[42] L. Lei, W. Dai, J. Man, H. Hu, Q. Jin, B. Zhang, Z. Tang, J. Nanobiotechnology 2023, 21, 482.

[43] J. Q. Huang, L. P. Zhao, X. Zhou, L. S. Liu, R. R. Zheng, F. A. Deng, Y. B. Liu, X. Y. Yu, S. Y. Li, H. Cheng, Small 2022, 18, e2107467.

[44] X. Song, Z. Zhou, H. Li, Y. Xue, X. Lu, I. Bahar, O. Kepp, M. C. Hung, G. Kroemer, Y. Wan, Cancer Discov. 2020, 10, 1872.

[45] W. Song, L. Shen, Y. Wang, Q. Liu, T. J. Goodwin, J. Li, O. Dorosheva, T. Liu, R. Liu, L. Huang, Nat. Commun. 2018, 9, 2237.

[46] H. Maeda, H. Nakamura, J. Fang, Adv. Drug Deliv. Rev. 2013, 65, 71.

[47] M. Franz, H. Rodriguez, C. Lopes, K. Zuberi, J. Montojo, G. D. Bader, Q. Morris, Nucleic Acids Res. 2018, 46, W60.

[48] S. He, L. Wang, D. Wu, F. Tong, H. Zhao, H. Li, T. Gong, H. Gao, Y. Zhou, Acta Pharm. Sin. B 2024, 14, 765.

[49] B. Feng, B. Hou, Z. Xu, M. Saeed, H. Yu, Y. Li, Adv. Mater. 2019, 31, e1902960.

RIGHTS & PERMISSIONS

2024 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.